Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock?
Transl Lung Cancer Res
.
2024 Oct 31;13(10):2856-2860.
doi: 10.21037/tlcr-24-594.
Epub 2024 Oct 17.
Authors
Alice Mogenet
1
2
,
Laurent Greillier
1
2
,
Pascale Tomasini
1
2
Affiliations
1
Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Marseille, France.
2
Aix Marseille University, CNRS, INSERM, Predictive Oncology Department, CRCM, Marseille, France.
PMID:
39507024
PMCID:
PMC11535845
DOI:
10.21037/tlcr-24-594
No abstract available
Keywords:
Lung cancer; biomarkers; immunotherapy.
Publication types
Editorial
Comment